APA (7th ed.) Citation

Spathis, A. D., Asvos, X., Ziavra, D., Karampelas, T., Topouzis, S., Cournia, Z., . . . Vassilatis, D. K. (2017). Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease. Proceedings of the National Academy of Sciences - PNAS, 114(15), 3999-4004. https://doi.org/10.1073/pnas.1616874114

Chicago Style (17th ed.) Citation

Spathis, Athanasios D., et al. "Nurr1: RXRα Heterodimer Activation as Monotherapy for Parkinson’s Disease." Proceedings of the National Academy of Sciences - PNAS 114, no. 15 (2017): 3999-4004. https://doi.org/10.1073/pnas.1616874114.

MLA (9th ed.) Citation

Spathis, Athanasios D., et al. "Nurr1: RXRα Heterodimer Activation as Monotherapy for Parkinson’s Disease." Proceedings of the National Academy of Sciences - PNAS, vol. 114, no. 15, 2017, pp. 3999-4004, https://doi.org/10.1073/pnas.1616874114.